Brief: Lantern Pharma Confirms No Exposure To Silicon Valley Bank, Silvergate Bank, Or Signature Bank
13/03/2023 10:39
March 13 (Reuters) - Lantern Pharma Inc LTRN.O :
* LANTERN PHARMA CONFIRMS IT HAD NO EXPOSURE TO SILICON
VALLEY
BANK (SVB), SILVERGATE BANK, OR SIGNATURE BANK
Source text for Eikon: ID:nBw1ZJkqha
Further company coverage: LTRN.O
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Receives Taiwan Approvals To Open Next Stage Of Phase 2 Harmonic Trial Of Lp-300 In Never-Smoker, Egfr-Mutant Nsclc
Brief: Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Q2 operating loss widens on warrant expenses tied to higher stock price
Lantern Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview